ArticleF1000Research2025
Development of a machine learning predictive model for early detection of breast cancer.
Article in F1000Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer remains a significant global health concern, with over 7.8 million cases reported in the last five years. Early detection and accurate classification are crucial for reducing mortality rates and improving outcomes. Machine learning (ML) has emerged as a transformative tool in medical imaging, enabling more efficient and accurate diagnostic processes. Objective: This study aims to develop a machine learning-based predictive model for early detection and classification of breast cancer using the Wisconsin Breast Cancer Diagnostic dataset. Methods: The dataset, comprising 569 samples and 33 features derived from fine needle aspirate biopsy images, was pre-processed through data cleaning, normalization using the Robust Scaler, and feature selection. Five supervised ML algorithms-Logistic Regression, Support Vector Classification (SVC) with linear and radial basis function (RBF) kernels, Decision Tree, and Random Forest-were implemented. Models were evaluated using performance metrics, including accuracy, precision, sensitivity, specificity, and F1 scores. Results: The SVC-RBF model demonstrated the highest accuracy (98.68%) and balanced performance across other metrics, making it the most effective classifier for distinguishing between benign and malignant tumors. Key features such as texture mean and area (worst) significantly contributed to classification accuracy. Conclusions: This study highlights the potential of ML algorithms, particularly SVC-RBF, to revolutionize breast cancer diagnostics through improved accuracy and efficiency. Future research should validate these findings with diverse datasets and explore their integration into clinical workflows to enhance decision-making and patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.